Michael Bielski

Form D signer

Michael Bielski

Chief Executive Officer at Spearhead Bio

Form D signer

Capital raised by Spearhead Bio

$1.2M+$1.2M latest round

1 Form D filing · first filed Jun 2026 · Saint Louis, MO

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2024
30D INTEREST: —

Career

1 company on file · founded 2024

Spearhead BioBiotech · Saint Louis, MOsince 2024

Chief Executive Officer

Signatory on Spearhead Bio's Form D filings · $1.2M raised across 1

Company filings

via EDGAR · Form D for Spearhead Bio1

DateCompanyFormAmountRole on filing

Jun 18, 2026Spearhead BioForm D+$1.2MChief Executive Officer

Form DJun 18, 2026 · Spearhead Bio+$1.2Mas Chief Executive Officer

Overview

Last filing Jun 18, 2026

Michael Bielski is on file as Chief Executive Officer at Spearhead Bio in Saint Louis, MO. Spearhead Bio has 1 Form D filing on record, $1.2M raised in total. Michael Bielski appears as a signatory on the company's filings.

Teammates

Spearhead Bio · 1

Thomas LauritaDirector

Products

Spearhead Bio · 1

TAHITI (Transposase Assisted Homology Independent Targeted Insertion)Agricultural genome engineering platform

A native genome engineering platform that enables seamless, targeted insertion of genes into crop genomes — in both transgenic and non-transgenic crops — using the plant's own natural DNA rather than foreign sequence.